[HTML][HTML] HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases

G Shanmugam, S Rakshit, K Sarkar - Translational Oncology, 2022 - Elsevier
Histone deacetylases (HDACs) are enzymes that play a key role in the epigenetic regulation
of gene expression by remodeling chromatin. Inhibition of HDACs is a prospective …

Anticancer activities of histone deacetylase inhibitors

JE Bolden, MJ Peart, RW Johnstone - Nature reviews Drug discovery, 2006 - nature.com
Histone deacetylases (HDACs) are enzymes involved in the remodelling of chromatin, and
have a key role in the epigenetic regulation of gene expression. In addition, the activity of …

[HTML][HTML] The role of histone deacetylases (HDACs) in human cancer

S Ropero, M Esteller - Molecular oncology, 2007 - Elsevier
The balance of histone acetylation and deacetylation is an epigenetic layer with a critical
role in the regulation of gene expression. Histone acetylation induced by histone acetyl …

Multiple myeloma in the marrow: pathogenesis and treatments

H Fairfield, C Falank, L Avery… - Annals of the New York …, 2016 - Wiley Online Library
Multiple myeloma (MM) is a B cell malignancy resulting in osteolytic lesions and fractures. In
the disease state, bone healing is limited owing to increased osteoclastic and decreased …

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical …

W Weichert, A Röske, V Gekeler, T Beckers… - British journal of …, 2008 - nature.com
High activity of histone deacetylases (HDACs) causes epigenetic alterations associated with
malignant cell behaviour. Consequently, HDAC inhibitors have entered late-phase clinical …

Epigenetic therapy of cancer with histone deacetylase inhibitors

KC Lakshmaiah, LA Jacob, S Aparna… - Journal of cancer …, 2014 - journals.lww.com
Epigenetics is the study of heritable alterations in gene expression that are not accompanied
by the corresponding change in DNA sequence. Three interlinked epigenetic processes …

Targeting histone deacetylases for cancer therapy: Trends and challenges

T Liang, F Wang, RM Elhassan, Y Cheng… - … Pharmaceutica Sinica B, 2023 - Elsevier
Dysregulation of histone deacetylases (HDACs) is closely related to tumor development and
progression. As promising anticancer targets, HDACs have gained a great deal of research …

Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges

P Atadja - Cancer letters, 2009 - Elsevier
The histone deacetylase (HDAC) inhibitors are emerging as a highly useful class of
anticancer agents that inhibit the enzyme HDAC involved in the deacetylation of histone and …

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

J Tan, S Cang, Y Ma, RL Petrillo, D Liu - Journal of hematology & oncology, 2010 - Springer
Histone deacetylases (HDACs) can regulate expression of tumor suppressor genes and
activities of transcriptional factors involved in both cancer initiation and progression through …

Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy

JS Carew, FJ Giles, ST Nawrocki - Cancer letters, 2008 - Elsevier
Histone deacetylases (HDACs) play an important role in the epigenetic regulation of gene
expression by catalyzing the removal of acetyl groups, stimulating chromatin condensation …